Catherine Mazzacco
Fortune : 319 560 $ au 31/05/2026
Fortune : 319 560 $ au 31/05/2026
Catherine Mazzacco is currently Independent Director at Sight Sciences, Inc. since 2023, Director at LEO Laboratories Ltd. since 2019, Independent Director at Krystal Biotech, Inc. since 2023, Independent Member-Supervisory Board at Les Laboratoires Servier SAS, and Member-Supervisory Board at Servier SAS since 2022.
Former roles include President, Chief Executive Officer & Director at LEO Pharma A from 2019 to 2021, Vice President-Global Commercial Operations at Abbott Laboratories from 2011 to 2017, and Senior Vice President-Global Commercial Operations at GE Healthcare, Inc. from 2018 to 2019.
Education includes undergraduate studies at the University of Compiègne.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SIGHT SCIENCES, INC. 0,12 % | 04/06/2026 | 65 753 ( 0,12 % ) | 319 560 $ | 31/05/2026 |
| 23/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Directeur/Membre du Conseil | 06/03/2023 |
| SIGHT SCIENCES, INC. | Directeur/Membre du Conseil | 08/06/2023 |
LEO Laboratories Ltd.
LEO Laboratories Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical goods | Directeur/Membre du Conseil | 16/09/2019 |
Les Laboratoires Servier SAS
Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for treatment of cancer, metabolism and neurology | Directeur/Membre du Conseil | - |
Servier SAS
Servier SAS Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Directeur/Membre du Conseil | 01/02/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
LEO Pharma A/S
LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Directeur Général | 01/11/2021 |
GE Healthcare, Inc.
GE Healthcare, Inc. Medical SpecialtiesHealth Technology Manufactures and retails diagnostic imaging & medical equipment | Corporate Officer/Principal | 01/05/2019 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/01/2017 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Sight Sciences, Inc.
Sight Sciences, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company | Health Technology |
Les Laboratoires Servier SAS
Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for treatment of cancer, metabolism and neurology | Health Technology |
LEO Pharma A/S
LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Health Services |
LEO Laboratories Ltd.
LEO Laboratories Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical goods | Distribution Services |
GE Healthcare, Inc.
GE Healthcare, Inc. Medical SpecialtiesHealth Technology Manufactures and retails diagnostic imaging & medical equipment | Health Technology |
University of Compiègne
University of Compiègne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Krystal Biotech, Inc.
Krystal Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops gene therapies to patients living with debilitating diseases | Health Technology |
Servier SAS
Servier SAS Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national